Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy

NCT01970254 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT01970254
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01970254 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy
Lead sponsor
M.D. Anderson Cancer Center
Phase
Observational
Overall status
Completed
Start date
June 24, 2013
Completion date
July 19, 2022
Enrollment
2,206 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, hbv, hepatitis b, hepatitis b infection, malignant neoplasm